Scientific Publications by FDA Staff
Nat Med 2013 Apr;19(4):452-7
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.
Xu Z, Qiu Q, Tian J, Smith JS, Conenello GM, Morita T, Byrnes AP
Adenovirus type 5 (Ad5) specifically binds coagulation factor X (FX), and FX is normally essential for intravenously injected Ad5 vectors to transduce the liver. We demonstrate that the ability of FX to enhance liver transduction by Ad5 vectors is due to an unexpected ability of FX to protect Ad5 from attack by the classical complement pathway. In vitro, naive mouse serum neutralized Ad5 when FX was blocked from binding Ad5. This neutralization was mediated by natural IgM and the classical complement pathway. In vivo, FX was essential for Ad5 vectors to transduce the livers of wild-type mice, but FX was not required for liver transduction in mice that lack antibodies, C1q or C4. We conclude that Ad5 recruits FX as a defense against complement and that the sensitivity of Ad5 to inactivation by complement must be taken into account when designing vectors for systemic gene therapy.
|Category: Journal Article|
|PubMed ID: #23524342||DOI: 10.1038/nm.3107|
|Includes FDA Authors from Scientific Area(s): Biologics|
|Entry Created: 2012-05-01||Entry Last Modified: 2013-04-21|